History, Dynamics, and Public Health Importance of Malaria Parasite Resistance

Clinical Microbiology Reviews

Volumn 17, Issue 1, 2004, Pages 235-254

  Talisuna, Ambrose O ^a,b   Bloland, Peter ^c   D'Alessandro, Umberto ^b  

^a MINISTRY OF HEALTH   (Uganda)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISIN DERIVATIVE; CHLOROQUINE; FANSIDAR; MEFLOQUINE;

DISEASE CONTROL; DISEASE TRANSMISSION; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESISTANCE; HUMAN; MALARIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PUBLIC HEALTH; REVIEW; TREATMENT PLANNING;

ANIMALS; ANTIMALARIALS; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PUBLIC HEALTH;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PROTOZOA;

EID: 1642474428     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.17.1.235-254.2004     Document Type: Review

References (238)

1. Ache, A., M. Escorihuela, E. Vivas, E. Paez, L. Miranda, A. Matos, W. Perez, O. Diaz, and E. Izarra. 2002. In vivo drug resistance of falciparum malaria in mining areas of Venezuela. Trop. Med. Int. Health 7:737-743.
2. al Arishi, H. M., A. F. el Awad, and L. A. al Bishi. 2001. Chloroquine-resistant Plasmodium falciparum malaria among children seen in a regional hospital, Tabuk, Saudi Arabia. Trans. R. Soc. Trop. Med. Hyg. 95:439-440.
3. Alecrim, M. D., W. Alecrim, and V. Macedo. 1999. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region. Rev. Soc. Bras. Med. Trop. 32:67-68.
4. Alene, G. D., and S. Bennett. 1996. Chloroquine resistance of Plasmodium falciparum malaria in Ethiopia and Eritrea. Trop. Med. Int. Health 1:810-815.
5. Anabwani, G. M., F. O. Esamai, and D. A. Menya. 1996. A randomised controlled trial to assess the relative efficacy of chloroquine, amodiaquine, halofantrine and Fansidar in the treatment of uncomplicated malaria in children. East Afr. Med. J. 73:155-158.
6. Anderson, R. M., and R. M. May. 1991. Infectious diseases of humans. Oxford University Press, Oxford, United Kingdom.
7. Reference deleted.
8. Antia-Obong, O. E., A. A. Alaribe, M. U. Young, A. Bassy, and B. V. Etim. 1997. Chloroquine-resistant Plasmodium falciparum among children in Calabar, south eastern Nigeria. Trop. Doct. 27:146-149.
9. Arias, A. E., and A. Corredor. 1989. Low response of Colombian strains of Plasmodium vivax to classical antimalarial therapy. Trop. Med. Parasitol. 40:21-23.
10. Arnot, D. 1998. Unstable malaria in Sudan: the influence of the dry season. Clone multiplicity of Plasmodium falciparum infections in individuals exposed to variable levels of disease transmission. Trans. R. Soc. Trop. Med. Hyg. 92:580-585.
11. Aronsson, B., E. Bengtsson, A. Bjorkman, P. O. Pehrson, L. Rombo, and M. Wahlgren. 1981. Chloroquine-resistant falciparum malaria in Madagascar and Kenya. Ann. Trop. Med. Parasitol. 75:367-373.
12. Babiker, A., and D. Walliker. 1997. Current views on the population structure of Plasmodium falciparum: Implications for control. Parasitol. Today 13:262-267.
13. Babiker, H. A., S. J. Pringle, A. Abdel-Muhsin, M. Mackinnon, P. Hunt, and D. Walliker. 2001. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. J. Infect. Dis. 183:1535-1538.
14. Baird, J. K., E. Caneta-Miguel, S. Masbar, D. G. Bustos, J. A. Abrenica, A. V. Layawen, J. M. Calulut, B. Leksana, and F. S. Wignall. 1996. Survey of resistance to chloroquine of falciparum and vivax malaria in Palawan, The Philippines. Trans. R. Soc. Trop. Med. Hyg. 90:413-414.
15. Baird, J. K., M. F. Sustriayu Nalim, H. Basri, S. Masbar, B. Leksana, E. Tjitra, R. M. Dewi, M. Khairani, and F. S. Wignall. 1996. Survey of resistance to chloroquine by Plasmodium vivax in Indonesia. Trans. R. Soc. Trop. Med. Hyg. 90:409-411.
16. Baird, J. K., T. Tiwari, G. J. Martin, C. L. Tamminga, T. M. Prout, J. Tjaden, P. P. Bravet, S. Rawlins, M. Ferrel, D. Carucci, and S. L. Hoffman. 2002. Chloroquine for the treatment of uncomplicated malaria in Guyana. Ann. Trop. Med. Parasitol. 96:339-348.
17. Baird, J. K., I. Wiady, D. J. Fryauff, M. A. Sutanihardja, B. Leksana, H. Widjaya, Kysdarmanto, and B. Subianto. 1997. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 56:627-631.
18. Barat, L. M., B. Himonga, S. Nkunika, M. Ettling, T. K. Ruebush, W. Kapelwa, and P. B. Bloland. 1998. A systematic approach to the development of a rational malaria treatment policy in Zambia. Trop. Med. Int. Health 3:535-542.
19. Barduagni, P., U. Schwartz, W. Nyamayaro, and T. L. Chauke. 1998. In vivo testing of the therapeutic efficacy of chloroquine on falciparum malaria infections in Chirundu, Mashonaland West, Zimbabwe. Cent. Afr. J. Med. 44:251-254.
20. Basco, L. K., D. P. Eldin, C. M. Wilson, J. Le Bras, and A. Mazabraud. 1995. Point mutations in the dihydrofolate reductase-thymidyl ate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol. Biochem. Parasitol. 69:135-138.
21. Basco, L. K., and P. Ringwald. 2001. Analysis of the key pfcrt point mutation and in vitro and in vivo response to chloroquine in Yaounde, Cameroon. J. Infect. Dis. 183:1828-1831.
22. Basco, L. K., A. Same-Ekobo, V. F. Ngane, M. Ndounga, T. Metoh, P. Ringwald, and G. Soula. 2002. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon. Bull. W. H. O. 80:538-545.
23. Bijl, H. M., J. Kager, D. W. Koetsier, and T. S. van der Werf. 2000. Chloroquine- and sulfadoxine-pyrimethamine-resistant Falciparum malaria in vivo - a pilot study in rural Zambia. Trop. Med. Int. Health 5:692-695.
24. Bloland, P. 2001. Drug resistance in malaria. WHO monograph WHO/ CDS/CSR/DRS/2001.4. World Health Organization, Geneva, Switzerland.
25. Bloland, P. B., and M. Ettling. 1999. Making malaria-treatment policy in the face of drug resistance. Ann. Trop. Med. Parasitol. 93:5-23.
26. Bloland, P. B., P. N. Kazembe, A. J. Oloo, B. Himonga, L. M. Barat, and T. K. Ruebush. 1998. Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa. Trop. Med. Int. Health 3:543-552.
27. Bloland, P. B., E. M. Lackritz, P. N. Kazembe, J. B. Were, R. Steketee, and C. C. Campbell. 1993. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J. Infect. Dis. 167:932-937.
28. Bojang, K. A., G. Schneider, S. Forck, S. K. Obaro, S. Jaffar, M. Pinder, J. Rowley, and B. M. Greenwood. 1998. A trial of Fansidar plus chloroquine or Fansidar alone for the treatment of uncomplicated malaria in Gambian children. Trans. R. Soc. Trop. Med. Hyg. 92:73-76.
29. Brasseur, P., R. Guiguemde, S. Diallo, V. Guiyedi, M. Kombila, P. Ringwald, and P. Olliaro. 1999. Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa. Trans. R. Soc. Trop. Med. Hyg. 93:645-650.
30. Bredenkamp, B. L., B. L. Sharp, S. D. Mthembu, D. N. Durrheim, and K. I. Barnes. 2001. Failure of sulphadoxine-pyrimethamine in treating Plasmodium falciparum malaria in KwaZulu-Natal. S. Afr. Med. J. 91:970-972.
31. Brockman, A., R. E. Paul, T. J. Anderson, I. Hackford, L. Phaiphun, S. Looareesuwan, F. Nosten, and K. P. Day. 1999. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am. J. Trop. Med. Hyg. 60:14-21.
32. Bruce-Chwatt, L. J., R. H. Black, C. J. Canfield, D. F. Clyde, W. Peters, and W. Wernsdorfer, 1986. Chemotherapy of malaria. WHO Monogr. Ser. 2:27.
33. Bzik, D. J., W. B. Li, T. Horii, and J. Inselburg. 1987. Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductasethymidylate synthase gene. Proc. Natl. Acad. Sci. USA 84:8360-8364.
34. Campbell, C. C., W. Chin, W. E. Collins, S. M. Teutsch, and D. M. Moss. 1979. Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist. Lancet ii:1151-1154.
35. Caraballo, A., and A. Rodriguez-Acosta. 1999. Chemotherapy of malaria and resistance to antimalarial drugs in Guayana area, Venezuela. Am. J. Trop. Med. Hyg. 61:120-124.
36. Carme, B., H. Guillo du Bodan, and M. Lallemant. 1992. Infant and child mortality and malaria in the Congo. The trend in the suburbs of Brazzaville between 1981 and 1988. Trop. Med. Parasitol. 43:177-180.
37. Castillo, C. M., L. E. Osorio, and G. I. Palma. 2002. Assessment of therapeutic response of Plasmodium vivax and Plasmodium falciparum to chloroquine in a Malaria transmission free area in Colombia. Mem. Inst. Oswaldo Cruz 97:559-562.
38. Cattamanchi, A., D. Kyabayinze, A. Hubbard, P. J. Rosenthal, and G. Dorsey. 2003. Distinguishing recrudescence from re-infection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of MSP1, MSP2 and GLURP. Am. J. Trop. Med. Hyg. 68:133-139.
39. Chen, N., B. Russell, J. Staley, B. Kotecka, P. Nasveld, and Q. Cheng. 2001. Sequence polymorphisms in pfcrt are strongly associated with chloroquine resistance in Plasmodium falciparum. J. Infect. Dis. 183:1543-1545.
40. Childs, G. E., T. Wimonwattrawatee, and N. Pooyindee. 1988. Evaluation of an in vitro assay system for drug susceptibility of field isolates of Plasmodium falciparum from southern Thailand. Am. J. Trop. Med. Hyg. 38:19-23.
41. Clarke, D., H. Odialla, J. Ouma, V. Kenny, R. MacCabe, B. Rapuoda, and W. M. Watkins. 1996. A malariometric survey in Turkana District, Kenya: chemosensitivity in vivo of Plasmodium falciparum infections and identity of the vector. Trans. R. Soc. Trop. Med. Hyg. 90:302-304.
42. Clyde, D. F. 1966. Drug resistance of malari parasites in Tanzania. East Afr. Med J. 43:405-408.
43. Coatney, G. R. 1963. Pitfalls in a discovery: the chronicle of chloroquine. Am. J. Trop. Med. Hyg. 12:121-128.
44. Collins, W. E., and G. M. Jeffery. 2002. Extended clearance time after treatment of infections with Plasmodium malariae may not be indicative of resistance to chloroquine. Am. J. Trop. Med. Hyg. 67:406-410.
45. Cowman, A. F., M. J. Morry, B. A. Biggs, G. A. Cross, and S. J. Foote. 1988. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 85:9109-9113.
46. Cross, A. P., and B. Singer. 1991. Modelling the development of resistance of Plasmodium falciparum to anti-malarial drugs. Trans. R. Soc. Trop. Med. Hyg. 85:349-355.
47. Curtis, C. F., and J. D. Lines. 1985. Impregnated fabrics against malaria mosquitoes. Parasitol. Today 1:147.
48. Curtis, C. F., and L. N. Otoo. 1986. A simple model of the build-up of resistance to mixtures of anti- malarial drugs. Trans. R. Soc. Trop. Med. Hyg. 80:889-892.
49. Deloron, P., J. Mayombo, A. Le Cardinal, J. Mezui-Me-Ndong, C. Bruzi-Baert, F. Lekoulou, and N. Elissa. 2000. Sulfadoxine-pyrimethamine for the treatment of Plasmodium falciparum malaria in Gabonese children. Trans. R. Soc. Trop. Med. Hyg. 94:188-190.
50. de Pecoulas, P. E., L. K. Basco, J. Le Bras, and A. Mazabraud. 1996. Association between antifol resistance in vitro and DHFR gene point mutation in Plasmodium falciparum isolates. Trans. R. Soc. Trop. Med. Hyg. 90:181-182.
51. Diourte, Y., A. Djimde, O. K. Doumbo, I. Sagara, Y. Coulibaly, A. Dicko, M. Diallo, M. Diakite, J. F. Cortese, and C. V. Plowe. 1999. Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali. Am. J. Trop. Med. Hyg. 60:475-478.
52. Di Perri, G., P. Olliaro, S. Nardi, R. Deganello, B. Allegranzi, S. Bonora, S. Vento, and E. Concia. 1998. Response of uncomplicated falciparum malaria to oral chloroquine and quinine in Burundi highlands. Acta Trop. 70:25-33.
53. Djimde, A., O. K. Doumbo, J. F. Cortese, K. Kayentao, S. Doumbo, Y. Diourte, A. Dicko, X. Z. Su, T. Nomura, D. A. Fidock, T. E. Wellems, C. V. Plowe, and D. Coulibaly. 2001. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 344:257-263.
54. Djimde, A., O. K. Doumbo, R. W. Steketee, and C. V. Plowe. 2001. Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet 358:890-891.
55. Doherty, J. F., A. D. Sadiq, L. Bayo, A. Alloueche, P. Olliaro, P. Milligan, L. von Seidlein, and M. Pinder. 1999. A randomized safety and tolerability trial of artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone for the treatment of uncomplicated malaria in Gambian children. Trans. R. Soc. Trop. Med. Hyg. 93:543-546.
56. Dorsey, G., M. R. Kamya, G. Ndeezi, J. N. Babirye, C. R. Phares, J. E. Olson, E. T. Katabira, and P. J. Rosenthal. 2000. Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda. Am. J. Trop. Med. Hyg. 62:686-692.
57. Dorsey, G., M. R. Kamya, A. Singh, and P. J. Rosenthal. 2001. Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. J. Infect. Dis. 183:1417-1420.
58. Dorsey, G., D. Njama, M. R. Kamya, A. Cattamanchi, D. Kyabayinze, S. G. Staedke, A. Gasasira, and P. J. Rosenthal. 2002. Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. Lancet 360:2031-2038.
59. Driessen, G. J., S. van Kerkhoven, B. J. Schouwenberg, G. Bonsu, and J. P. Verhave. 2002. Sulphadoxine/pyrimethamine: an appropriate first-line alternative for the treatment of uncomplicated falciparum malaria in Ghanaian children under 5 years of age. Trop. Med. Int. Health 7:577-583.
60. Druilhe, P., A. Moreno, C. Blanc, P. H. Brasseur, and P. Jacquier. 2001. A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay. Am. J. Trop. Med. Hyg. 64:233-241
61. Durand, R., S. Jafari, O. Bouchaud, P. Ralaimazava, A. Keundjian, and J. Le Bras. 2001. Plasmodium falciparum: pfcrt and DHFR mutations are associated with failure of chloroquine plus proguanil prophylaxis in travelers. J. Infect. Dis. 184:1633-1634.
62. Dzekunov, S. M., L. M. Ursos, and P. D. Roepe. 2000. Digestive vacuolar pH of intact intraerythrocytic P. falciparum either sensitive or resistant to chloroquinc. Mol. Biochem. Parasitol. 110:107-124.
63. Ehrhardt, S., F. P. Mockenhaupt, P. Agana-Nsiire, A. Mathieu, S. D. Anemana, K. Stark, R. N. Otchwemah, and U. Bienzle. 2002. Efficacy of chloroquine in the treatment of uncomplicated, Plasmodium falciparum malaria in northern Ghana. Ann. Trop. Med. Parasitol. 96:239-247.
64. Ejov, M. N., T. Tun, S. Aung, and K. Sein. 1999. Response of falciparum malaria to different antimalarials in Myanmar. Bull. W. H. O. 77:244-249.
65. Ekue, J. M., A. M. Ulrich, and E. K. Njelesani. 1983. Plasmodium malaria resistant to chloroquine in a Zambian living in Zambia. Br. Med. J. Clin. Res. Ed. 286:1315-1316.
66. Ekvall, H., Z. Premji, and A. Bjorkman. 1998. Chloroquine treatment for uncomplicated childhood malaria in an area with drug resistance: early treatment failure aggravates anaemia. Trans. R. Soc. Trop. Med. Hyg. 92:556-560.
67. Elliotson, J. 1844. The principles and practice of medicine. Carey and Hart, Philadelphia, Pa.
68. Ezedinachi, E. 1996. In vivo efficacy of chloroquine, halofantrine, pyrimethamine-sulfadoxine and qinghaosu (artesunate) in the treatment of malaria in Calabar, Nigeria. Cent. Afr. J. Med. 42:109-111.
69. Falade, C. O., L. A. Salako, A. Sowunmi, A. M. Oduola, and P. Larcier. 1997. Comparative efficacy of halofantrine, chloroquine and sulfadoxine-pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children. Trans. R. Soc. Trop. Med. Hyg. 91:58-62.
70. Farnert, A., A. P. Arez, H. A. Babiker, H. P. Beck, A. Benito, A. Bjorkman, M. C. Bruce, D. J. Conway, K. P. Day, L. Henning, O. Mercereau-Puijalon, L. C. Ranford-Cartwright, J. M. Rubio, G. Snounou, D. Walliker, J. Zwetyenga, and V. E. do Rosario. 2001. Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Trans. R. Soc. Trop. Med. Hyg. 95:225-232.
71. Fidock, D. A., T. Nomura, A. K. Talley, R. A. Cooper, S. M. Dzekunov, M. T. Ferdig, L. M. Ursos, A. B. Sidhu, B. Naude, K. W. Deitsch, X. Z. Su, J. C. Wootton, P. D. Roepe, and T. E. Wellems. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6:861-871.
72. Fogh, S., S. Jepsen, and P. Effersoe. 1979. Chloroquine-resistant Plasmodium falciparum malaria in Kenya. Trans. R. Soc. Trop. Med. Hyg. 73:228-229.
73. Fogh, S., S. Jepsen, and R. H. Mataya. 1984. R-III chloroquine-resistant Plasmodium falciparum malaria from northern Malawi. Trans. R. Soc. Trop. Med. Hyg. 78:282.
74. Foote, S. J., and A. F. Cowman. 1994. The mode of action and the mechanism of resistance to antimalarial drugs. Acta Trop. 56:157-171.
75. Foote, S. J., D. E. Kyle, R. K. Martin, A. M. Oduola, K. Forsyth, D. J. Kemp, and A. F. Cowman. 1990. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345:255-258.
76. Fryauff, D. J., B. Leksana, S. Masbar, I. Wiady, P. Sismadi, A. I. Susanti, H. S. Nagesha, Syafruddin, S. Atmosoedjono, M. J. Bangs, and J. K. Baird. 2002. The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia. Ann. Trop. Med. Parasitol. 96:447-462.
77. Fryauff, D. J., Soekartono, S. Tuti, B. Leksana, Suradi, S. Tandayu, and J. K. Baird. 1998. Survey of resistance in vivo to chloroquine of Plasmodium falciparum and P. vivax in North Sulawesi, Indonesia. Trans. R. Soc. Trop. Med. Hyg. 92:82-83.
78. Fryauff, D. J., I. Sumawinata, Purnomo, T. L. Richie, E. Tjitra, M. J. Bangs, A. Kadir, and G. Ingkokusumo. 1999. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 60:542-546.
79. Fryauff, D. J., S. Tuti, A. Mardi, S. Mashar, R. Patipelohi, B. Leksana, K. C. Kain, M. J. Bangs, T. L. Richie, and J. K. Baird. 1998. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. Am. J. Trop. Med. Hyg. 59:513-518.
80. Ghalib, H. W., S. Al Ghamdi, M. Akood, A. E. Haridi, A. A. Ageel, and R. E. Abdalla. 2001. Therapeutic efficacy of chloroquine against uncomplicated, Plasmodium falciparum malaria in south-western Saudi Arabia. Ann. Trop. Med. Parasitol. 95:773-779.
81. Gogtay, N. J., S. Desai, V. S. Kadam, K. D. Kamtekar, S. S. Dalvi, and N. A. Kshirsagar. 2000. A randomized, parallel-group study in Mumbai (Bombay), comparing chloroquine with chloroquine plus sulfadoxine-pyrimethamine in the treatment of adults with acute, uncomplicated, Plasmodium falciparum malaria. Ann. Trop. Med. Parasitol. 94:309-312.
82. Gorissen, E., G. Ashruf, M. Lamboo, J. Bennebroek, S. Gikunda, G. Mbaruku, and P. A. Kager. 2000. In vivo efficacy study of amodiaquine and sulfadoxine/ pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania. Trop. Med. Int. Health 5:459-463.
83. Govere, J. M., J. J. la Grange, D. N. Durrheim, J. A. Freese, B. L. Sharp, A. Mabuza, N. Mugomezulu, and B. L. Bredenkamp. 1999. Sulfadoxine-pyrimethamine effectiveness against Plasmodium falciparum malaria in Mpumalanga Province, South Africa. Trans. R. Soc. Trop. Med. Hyg. 93: 644.
84. Greenberg, A. E., M. Ntumbanzondo, N. Ntula, L. Mawa, J. Howell, and F. Davachi. 1989. Hospital-based surveillance of malaria-related paediatric morbidity and mortality in Kinshasa, Zaire. Bull. W. H. O. 67:189-196.
85. Greenwood, B. 2002. The molecular epidemiology of malaria. Trop. Med. Int. Health 7:1012-1021.
86. Grimmond, T. R., K. O. Donovan, and I. D. Riley. 1976. Chloroquine resistant malaria in Papua New Guinea. Papua New Guinea Med. J. 19: 184-185.
87. Guthmann, J. P., C. Cetre, F. Suzan, S. Darovare, and F. Morin. 1996. Field research, relief work and war: does chloroquine-resistance occur in displaced populations of southern Sudan? Trop. Doct. 26:89-90.
88. Harinasuta, T., P. Suntharasamai, and C. Viravan. 1965. Chloroquine-resistant falciparum malaria in Thailand. Lancet ii.657-660.
89. Hastings, I. M. 1997. A model for the origins and spread of drug-resistant malaria. Parasitology 115:133-141.
90. Hastings, I. M. 2001. Modelling parasite drug resistance: lessons for management and control strategies. Trop. Med. Int. Health 6:883-890.
91. Hastings, I. M. 2003. Malaria control and the evolution of drug resistance: an intriguing link. Trends Parasitol. 19:70-73.
92. Hastings, I. M., P. G. Bray, and S. A. Ward. 2002. Parasitology. A requiem for chloroquine. Science 298:74-75.
93. Hastings, I. M., and U. D'Alessandro. 2000. Modelling a predictable disaster: the rise and spread of drug-resistantmalaria. Parasitol. Today 16:340-347.
94. Hastings, I. M., and M. J. Mackinnon. 1998. The emergence of drug-resistant malaria. Parasitology 117:411-417.
95. Hastings, I. M., W. M. Watkins, and N. J. White. 2002. The evolution of drug-resistant malaria: the role of drug elimination half-life. Philos. Trans. R. Soc. London Ser. B 357:505-519.
96. Hastings, M. D., S. J. Bates, E. A. Blackstone, S. M. Monks, T. K. Mutabingwa, and C. S. Sibley. 2002. Highly pyrimethamine-resistant alleles of dihydrofol ate reductase in isolates of Plasmodium falciparum from Tanzania. Trans. R. Soc. Trop. Med. Hyg. 96:674-676.
97. Hatz, C., S. Abdulla, R. Mull, D. Schellenberg, I. Gathmann, P. Kibatala, H. P. Beck, M. Tanner, and C. Royce. 1998. Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years. Trop. Med. Int. Health 3:498-504.
98. Hay, S. I., J. Cox, D. J. Rogers, S. E. Randolph, D. I. Stern, G. D. Shanks, M. F. Myers, and R. W. Snow. 2002. Climate change and the resurgence of malaria in the East African highlands. Nature 415:905-909.
99. Henry, M. C., M. Kone, P. Guillet, and J. Mouchet. 1998. Chloroquine resistance and malaria control in Ivory Coast. Sante 8:287-291. (In French.)
100. Hess, F. I., A. lannuzzi, J. Leafasia, D. Cowdrey, H. D. Nothdurft, F. von Sonnenburg, T. Loscher, and K. H. Rieckmann. 1996. Risk factors of chloroquine resistance in Plasmodium falciparum malaria. Acta Trop. 61: 293-306.
101. Hill, W. G., H. A. Babiker, L. C. Ranford-Cartwright, and D. Walliker. 1995. Estimation of inbreeding coefficients from genotyic data on multiple alleles, and application to estimation of clonality in malaria parasites. Genet. Res. 65:53-61.
102. Hong-Ping, G., Z. Yao, D. Qian, Y. Jin-Hua, J. Kai-Xun, and Z. Min. 1998. The in vivo sensitivity of Plasmodium falciparum to chloroquine in the Red River basin, Yunnan, China. Southeast Asian J. Trop. Med. Public Health 29:692-695.
103. Irion, A., I. Felger, S. Abdulla, T. Smith, R. Mull, M. Tanner, C. Hatz, and H. P. Beck. 1998. Distinction of recrudescences from new infections by PCR-RFLP analysis in a comparative trial of CGP 56 697 and chloroquine in Tanzanian children. Trop. Med. Int. Health 3:490-497.
104. Kamya, M. R., N. N. Bakyaita, A. O. Talisuna, W. M. Were, and S. G. Staedke. 2002. Increasing antimalarial drug resistance in Uganda and revision of the national drug policy. Trop. Med. Int. Health 7:1031-1041.
105. Kamya, M. R., G. Dorsey, A. Gasasira, G. Ndeezi, J. N. Babirye, S. G. Staedke, and P. J. Rosenthal. 2001. The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Trans. R. Soc. Trop. Med. Hyg. 95:50-55.
106. Kihamia, C. M., and H. S. Gill. 1982. Chloroquine-resistant falciparum malaria in semi-immune African Tanzania. Lancet ii:43.
107. Krogstad, D. J., I. Y. Gluzman, D. E. Kyle, A. M. Oduola, S. K. Martin, W. K. Milhous, and P. H. Schlesinger. 1987. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238: 1283-1285.
108. Kshirsagar, N. A., N. J. Cogtay, D. Rajgor, S. S. Dalvi, and M. Wakde. 2000. An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay), India. Ann. Trop. Med. Parasitol. 94:189-190.
109. Kublin, J. G., F. K. Dzinjalamala, D. D. Kamwendo, E. M. Malkin, J. F. Cortese, L. M. Martino, R. A. Mukadam, S. J. Rogerson, A. G. Lescano, M. E. Molyneux, P. A. Winstanley, P. Chimpeni, T. E. Taylor, and C. V. Plowe. 2002. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 185:380-388.
110. Kublin, J. G., J. F. Cortese, E. M. Njuju, R. A. G. Mukadam, J. J. Wirima, P. N. Kazembe, A. A. Djimde, B. Kouriba, T. E. Taylor, and C. V. Plowe. 2003. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J. Infect. Dis. 187:1870-1875.
111. Kyosiimire-Lugemwa, J., A. J. Nalunkuma-Kazibwe, G. Mujuzi, H. Mulindwa, A. Talisuna, and T. G. Egwang. 2002. The Lys-76-Thr mutation in PfCRT and chloroquine resistance in Plasmodium falciparum isolates from Uganda. Trans. R. Soc. Trop. Med. Hyg. 96:91-95.
112. Leclerc, M. C., P. Durand, T. De Meeus, V. Rovert, and F. Renaud. 2002. Genetic diversity and population structure of Plasmodium falciparum isolates from Dakar, Senegal, investigated from microsatellite and antigen determinanat loci. Microbes Infect. 4:685-692.
113. Legros, D., K. Johnson, P. Houpikian, M. Makanga, J. K. Kabakyenga, A. O. Talisuna, and W. R. Taylor. 2002. Clinical efficacy of chloroquine or sulfadoxine-pyrimethamine in children under five from south-western Uganda with uncomplicated falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 96:199-201.
114. le Hesran, J. Y., C. Boudin, M. Cot, P. Personne, R. Chambon, V. Foumane, J. P. Verhave, and C. de Vries. 1997. In-vivo resistance of Plasmodium falciparum to chloroquine and amodiaquine in south Cameroon and age-related efficacy of the drugs. Ann. Trop. Med. Parasitol. 91:661-664.
115. Reference deleted.
116. Lemeshow, S., and S. Taber. 1991. Lot quality assurance sampling: single-and double-sampling plans. World Health Stat. Q. 44:115-132.
117. Lokman, H. S., S. W. Sharifah Roohi, Y. Zurkurnai, R. A. Noor, S. M. Mansor, K. Palmer, V. Navaratnam, and J. W. Mak. 1996. Plasmodium falciparum: increased proportion of severe resistance (RII and RIII) to chloroquine and high rate of resistance to sulfadoxine-pyrimethamine in Peninsular Malaysia after two decades. Trans. R. Soc. Trop. Med. Hyg. 90:294-297.
118. Looareesuwan, S., C. Viravan, H. K. Webster, D. E. Kyle, D. B. Hutchinson, and C. J. Canfield. 1996. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am. J. Trop. Med. Hyg. 54:62-66.
119. Mabuza, A., J. Govere, D. Durrhelm, N. Mngomezulu, B. Bredenkamp, K. Barnes, and B. Sharp. 2001. Therapeutic efficacy of sulfadoxine-pyrimethamine in uncomplicated Plasmodium falciparum malaria 3 years after introduction in Mpumalanga. S. Afr. Med. J. 91:975-978.
120. MacArthur, J., G. M. Stennies, A. Macheso, M. S. Kolczak, M. D. Green, D. Ali, L. M. Barat, P. N. Kazembe, and T. K. Ruebush. 2001. Efficacy of mefloquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum infection in Machinga District, Malawi, 1998. Am. J. Trop. Med. Hyg. 65:679-684.
121. Mackinnon, M. J., and I. M. Hastings. 1998. The evolution of multiple drug resistance in malaria parasites. Trans. R. Soc. Trop. Med. Hyg. 92:188-195.
122. Magesa, S. M., K. Y. Mdira, A. Farnert, P. E. Simonsen, I. C. Bygbjerg, and P. H. Jakobsen. 2001. Distinguishing Plasmodium falciparum treatment failures from re-infections by using polymerase chain reaction genotyping in a holoendemic area in northeastern Tanzania. Am. J. Trop. Med. Hyg. 65:477-483.
123. Maguire, J. D., I. W. Sumawinata, S. Masbar, B. Laksana, P. Prodjodipuro, I. Susanti, P. Sismadi, N. Mahmud, M. J. Bangs, and J. K. Baird. 2002. Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia. Lancet 360:58-60.
124. Maguire, J. D., A. I. Susanti, Krisin, P. Sismadi, D. J. Fryauff, and J. K. Baird. 2001. The T76 mutation in the pfcrt gene of Plasmodium falciparum and clinical chloroquine resistance phenotypes in Papua, Indonesia. Ann. Trop. Med. Parasitol. 95:559-572.
125. Mahomva, A. I., D. E. Peterson, and L. Rakata. 1996. Chloroquine resistant falciparum malaria in Mutare District, eastern Zimbabwe. Cent. Afr. J. Med. 42:112-113.
126. Makler, M. T., J. M. Ries, J. A. Williams, J. E. Bancroft, R. C. Piper, B. L. Gibbins, and D. J. Hinrichs. 1993. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am. J. Trop. Med. Hyg. 48:739-741.
127. Makono, R., and S. Sibanda. 1999. Review of the prevalence of malaria in Zimbabwe with specific reference to parasite drug resistance (1984-96). Trans. R. Soc. Trop. Med. Hyg. 93:449-452.
128. Markwalder, K. A., and H. E. Meyer. 1982. Possible sulfadoxine-pyrimethamine resistance in Plasmodium falciparum malaria from Kenya. Trans. R. Soc. Trop. Med. Hyg. 76:281.
129. Mayor, A. G., X. Gomez-Olive, J. J. Aponte, S. Casimiro, S. Mabunda, M. Dgedge, A. Barreto, and P. L. Alonso. 2001. Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique. J. Infect. Dis. 183:1413-1416.
130. McCormack, C. P. 1984. Human ecology and behaviour in malaria control in tropical Afica. Bull. W. H. O. 62:81-87.
131. McIntosh, H. M., and B. M. Greenwood. 1998. Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria-a systematic review. Ann. Trop. Med. Parasitol. 92:265-270.
132. McIntosh, H. M., and P. Olliaro. 2000. Artemisinin derivatives for treating uncomplicated malaria. Cochrane Database Syst. Rev. CD000256.
133. Mehlotra, R. K., H. Fujioka, P. D. Roepe, O. Janneh, L. M. Ursos, V. Jacobs-Lorena, D. T. McNamara, M. J. Bockarie, J. W. Kazura, D. E. Kyle, D. A. Fidock, and P. A. Zimmerman. 2001. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc. Natl. Acad. Sci. USA 98:12689-12694.
134. Mendez, F., A. Munoz, G. Carrasquilla, D. Jurado, M. Arevalo-Herrera, J. F. Cortese, and C. V. Plowe. 2002. Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. Am. J. Epidemiol. 156:230-238.
135. Molyneux, D. H., K. Floyd, G. Barnish, and E. M. Fevre. 1999. Transmission control and drug resistance in malaria: a crucial interaction. Parasitol. Today 15:238-240.
136. Moore, D. V., and J. E. Lanier. 1961. Observations on two Plasmodium falciparum infections with abnormal response to chloroquine. Am. J. Trop. Med. Hyg. 10:5-9.
137. Mulindwa, H. C., H. Mayanja-Kizza, and J. Freers. 2002. Resistance patterns of Plasmodium falciparum malaria to chloroquine in Kampala, Uganda. East Afr. Med. J. 79:115-119.
138. Muller, O., M. B. van Hensbroek, S. Jaffar, C. Drakeley, C. Okorie, D. Joof, M. Pinder, and B. Greenwood. 1996. A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria. Trop. Med. Int. Health 1:124-132.
139. Mutabingwa, T., A. Nzila, E. Mberu, E. Nduati, P. Winstanley, E. Hills, and W. Watkins. 2001. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet 358:1218-1223.
140. Myat, P. K., O. Myint, L. Myint, Z. Thaw, H. A. Kyin, and N. Y. Nwe. 1993. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Trans. R. Soc. Trop. Med. Hyg. 87:687.
141. Nagesha, H. S., S. Din, G. J. Casey, A. I. Susanti, D. J. Fryauff, J. C. Reeder, and A. F. Cowman. 2001. Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia. Trans. R. Soc. Trop. Med. Hyg. 95:43-49.
142. Najera, J. A. 1990. Malaria control: present situation and need for historical research. Parassitologia 32:215-229.
143. Neiva, A. 1910. Ueber die Bildung einur chininresistenten Rasse des Malariaparasiten. Mem. Inst. Oswaldo Cruz 2:131-140.
144. Nocht, B., and H. Werner. 1910. Beobachtungen uber eine relative Chininresistenz bei malaria aus brasilien. Dtsch. Med. Wochenschr. 36:1557-1560.
145. Noedl, H., W. H. Wernsdorfer, R. S. Miller, and C. Wongsrichanalai. 2002. Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. Antimicrob. Agents Chemother. 46:1658-1664
146. Nosten, F., F. ter Kuile, T. Chongsuphajaisiddhi, C. Luxemburger, H. K. Webster, M. Edstein, L. Phaipun, K. L. Thew, and N. J. White. 1991. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 337:1140-1143.
147. Nosten, F., M. van Vugt, R. Price, C. Luxemburger, K. L. Thway, A. Brockman, R. McGready, F. ter Kuile, S. Looareesuwan, and N. J. White. 2000. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356:297-302.
148. Nwanyanwu, O. C., C. Ziba, P. Kazembe, L. Chitsulo, J. J. Wirima, N. Kumwenda, and S. C. Redd. 1996. Efficacy of sulphadoxine/pyrimethamine for Plasmodium falciparum malaria in Malawian children under five years of age. Trop. Med. Int. Health 1:231-235.
149. Nzila, A. M., E. K. Mberu, J. Sulo, H. Dayo, P. A. Winstanley, C. H. Sibley, and W. M. Watkins. 2000. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. Antimicrob. Agents Chemother. 44:991-996.
150. Nzila, A. M., E. Nduati, E. K. Mberu, S. C. Hopkins, S. A. Monks, P. A. Winstanley, and W. M. Watkins. 2000. Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine/sulfadoxine compared with the shorter-acting chlorproguanil/ dapsone on Kenyan Plasmodium falciparum. J. Infect. Dis. 181:2023-2028.
151. Ogutu, B. R., B. L. Smoak, R. W. Nduati, D. A. Mbori-Ngacha, F. Mwathe, and G. D. Shanks. 2000. The efficacy of pyrimethamine-sulfadoxine (Fansidar) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children. Trans. R. Soc. Trop. Med. Hyg. 94:83-84.
152. Olliaro, P., W. R. Taylor, and J. Rigal. 2001. Controlling malaria: challenges and solutions. Trop. Med. Int. Health 6:922-927.
153. Omar, S. A., A. Bakari, A. Owiti, I. S. Adagu, and D. C. Warhurst. 2001. Co-trimoxazole compared with sulfadoxine-pyrimethamine in the treatment of uncomplicated malaria in Kenyan children. Trans. R. Soc. Trop. Med. Hyg. 95:657-660.
154. Onori, E. 1984. The problem of Plasmodium falciparum drug resistance in Africa south of the Sahara. Bull. W. H. O. 62(Suppl.):55-62.
155. Onori, E., B. Grab, P. Ambroise-Thomas, and J. Thelu. 1982. Incipient resistance of Plasmodium falciparum to chloroquine among a semi-immune population of the United Republic of Tanzania. 2. The impact of chloroquine used as a chemosuppressant on the immune status of the population. Bull. W. H. O. 60:899-906.
156. Osorio, L. E., L. E. Giraldo, L. F. Grajales, A. L. Arriaga, A. L. Andrade, T. K. Ruebush, and L. M. Barat. 1999. Assessment of therapeutic response of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in an area of low malaria transmission in Colombia. Am. J. Trop. Med. Hyg. 61:968-972.
157. Overbosch, D., van den Wall Bake AW, P. C. Stuiver, and H. J. van der Kaay. 1984. Chloroquine-resistant falciparum malaria from Malawi. Trop. Geogr. Med. 36:71-72.
158. Paul, R. E., M. J. Packer, M. Walmsley, M. Lagog, L. C. Ranford-Cartwright, R. Paru, and K. P. Day. 1995. Mating patterns in malaria parasite populations of Papua New Guinea. Science 269:1709-1711.
159. Payne, D. 1988. Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum. Parasitol. Today 4:112-115.
160. Peters, W. 1987. Chemotherapy and drug resistance in malaria, 2nd ed. Academic Press, Inc., New York, N.Y.
161. Peterson, D. S., W. K. Milhous, and T. E. Wellems. 1990. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. USA 87:3018-3022.
162. Phan, G. T., P. J. de Vries, B. Q. Tran, H. Q. Le, N. V. Nguyen, T. V. Nguyen, S. H. Heisterkamp, and P. A. Kager. 2002. Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam. Trop. Med. Int. Health 7:858-864.
163. Phillips, E. J., J. S. Keystone, and K. C. Kain. 1996. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin. Infect. Dis. 23:1171-1173.
164. Pillai, D. R., A. C. Labbe, V. Vanisaveth, B. Hongvangthong, S. Pomphida, S. Inkathone, K. Zhong, and K. C. Kain. 2001. Plasmodium falciparum malaria in Laos: chloroquine treatment outcome and predictive value of molecular markers. J. Infect. Dis. 183:789-795.
165. Reference deleted.
166. Plowe, C. V., A. Djimde, T. E. Wellems, S. Diop, B. Kouriba, and O. K. Doumbo. 1996. Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance. Am. J. Trop. Med. Hyg. 55:467-471.
167. Plowe, C. V., O. K. Doumbo, A. Djimde, K. Kayentao, Y. Diourte, S. N. Doumbo, D. Coulibaly, M. Thera, T. E. Wellems, and D. A. Diallo. 2001. Chloroquine treatment of uncomplicated Plasmodium falciparum malaria in Mali: parasitologic resistance versus therapeutic efficacy. Am. J. Trop. Med. Hyg. 64:242-246.
168. Price, R. N., F. Nosten, C. Luxemburger, F. O. ter Kuile, L. Paiphun, T. Chongsuphajaisiddhi, and N. J. White. 1996. Effects of artemisinin derivatives on malaria transmissibility. Lancet 347:1654-1658.
169. Rab, M. A., T. W. Freeman, N. Durrani, D. de Poerck, and M. W. Rowland. 2001. Resistance of Plasmodium falciparum malaria to chloroquine is widespread in eastern Afghanistan. Ann. Trop. Med. Parasitol. 95:41-46.
170. Rahman, M. R., D. C. Paul, M. Rashid, A. Ghosh, A. M. Bangali, M. A. Jalil, and M. A. Faiz. 2001. A randomized controlled trial on the efficacy of alternative treatment regimens for uncomplicated falciparum malaria in a multidrug-resistant falciparum area of Bangladesh-narrowing the options for the National Malaria Control Programme? Trans. R. Soc. Trop. Med. Hyg. 95:661-667.
171. Ranford-Cartwright, L. C., K. L. Johnston, A. M. Abdel-Muhsin, B. K. Khan, and H. A. Babiker. 2002. Critical comparison of molecular genotyping methods for detection of drug-resistant Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 96:568-572.
172. Ranford-Cartwright, L. C., J. Taylor, T. Umasunthar, L. H. Taylor, H. A. Babiker, B. Lell, J. R. Schmidt-Ott, L. G. Lehman, D. Walliker, and P. G. Kremsner. 1997. Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans. R. Soc. Trop. Med. Hyg. 91:719-724.
173. Reed, M. B., K. J. Saliba, S. R. Caruana, K. Kirk, and A. F. Cowman. 2000. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403:906-909.
174. Rieckmann, K. H., D. R. Davis, and D. C. Hutton. 1989. Plasmodium vivax resistance to chloroquine? Lancet ii:1183-1184.
175. Ringwald, P., and L. K. Basco. 1999. Comparison of in vivo and in vitro tests of resistance in patients treated with chloroquine in Yaounde, Cameroon. Bull. W. H. O. 77:34-43.
176. Robert, V., H. P. Awono-Ambene, J. Y. le Hesran, and J. F. Trape. 2000. Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine. Am. J. Trop. Med. Hyg. 62:210-216.
177. Rogier, C., A. Tall, N. Diagne, D. Fontenille, A. Spiegel, and J. F. Trape. 1999. Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal. Parassitologia 41:255-259.
178. Ronn, A. M., H. A. Msangeni, J. Mhina, W. H. Wernsdorfer, and I. C. Bygbjerg. 1996. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Trans. R. Soc. Trop. Med. Hyg. 90:179-181.
179. Rowland, M., N. Durrani, S. Hewitt, and E. Sondorp. 1997. Resistance of falciparum malaria to chloroquine and sulfadoxine-pyrimethamine in Afghan refugee settlements in western Pakistan: surveys by the general health services using a simplified in vivo test. Trop. Med. Int. Health 2:1049-1056.
180. Rwagacondo, C. E., F. Niyitegeka, J. Sarushi, C. Karema, V. Mugisha, J. C. Dujardin, C. Van Overmeir, J. van den Ende, and U. D'Alessandro. 2003. Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate. Am. J. Trop. Med. Hyg. 68:743-747.
181. Sanchez, C. P., S. Wunsch, and M. Lanzer. 1997. Identification of a chloroquine importer in Plasmodium falciparum. Differences in import kinetics are genetically linked with the chloroquine-resistant phenotype. J. Biol. Chem. 272.2652-2658.
182. Schapira, A., P. F. Beales, and M. E. Halloran. 1993. Malaria: living with drug resistance. Parasitol. Today 9:168-174.
183. Schuurkamp, G. J., P. E. Spicer, R. K. Kereu, P. K. Bulungol, and K. H. Rieckmann. 1992. Chloroquine-resistant Plasmodium vivax in Papua New Guinea. Trans. R. Soc. Trop. Med. Hyg. 86:121-122.
184. Schwartz, I. K., E. M. Lackritz, and L. C. Patchen. 1991. Chloroquine-resistant Plasmodium vivax from Indonesia. N. Engl. J. Med. 324:927.
185. Shaffer, N., K. Hedberg, F. Davachi, B. Lyamba, J. G. Breman, O. S. Masisa, F. Behets, A. Hightower, and P. Nguyen-Dinh. 1990. Trends and risk factors for HIV-1 seropositivity among outpatient children, Kinshasa, Zaire. AIDS 4:1231-1236.
186. Sharma, Y. D., S. Biswas, C. R. Pillai, M. A. Ansari, T. Adak, and C. U. Devi. 1996. High prevalence of chloroquine resistant Plasmodium falciparum infection in Rajasthan epidemic. Acta Trop. 62:135-141.
187. Sibley, C. H., J. E. Hyde, P. F. Sims, C. V. Plowe, J. G. Kublin, E. K. Mberu, A. F. Cowman, P. A. Winstanley, W. M. Watkins, and A. M. Nzila. 2001. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 17:582-588.
188. Sidhu, A. B., D. Verdier-Pinard, and D. A. Fidock. 2002. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298:210-213.
189. Sims, P., P. Wang, and J. E. Hyde. 1999. Selection and synergy in Plasmodium falciparum. Parasitol. Today 15:132-134.
190. Slatter, M. J., K. Pettengell, and R. K. Taylor. 1983. Chloroquine-resistant malaria. S. Afr. Med. J. 63:838.
191. Smithuis, F. M., F. Monti, M. Grundl, A. Z. Oo, T. T. Kyaw, O. Phe, and N. J. White. 1997. Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar. Trans. R. Soc. Trop. Med. Hyg. 91:468-472.
192. Sowunmi, A., A. I. Ayede, A. G. Falade, V. N. Ndikum, C. O. Sowunmi, A. A. Adedeji, C. O. Falade, T. C. Happi, and A. M. Oduola. 2001. Randomized comparison of chloroquine and amodiaquine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. Ann. Trop. Med. Parasitol. 95:549-558.
193. Sowunmi, A., A. M. Oduola, O. A. Ogundahunsi, and L. A. Salako. 1998. Comparative efficacy of chloroquine plus chlorpheniramine and pyrimethamine/sulfadoxine in acute uncomplicated falciparum malaria in Nigerian children. Trans. R. Soc. Trop. Med. Hyg. 92:77-81.
194. Spencer, H. C., D. M. Kariuki, and D. K. Koech. 1983. Chloroquine resistance in Plasmodium falciparum from Kenyan infants. Am. J. Trop. Med. Hyg. 32:922-925.
195. Staedke, S. G., M. R. Kamya, G. Dorsey, A. Gasasira, G. Ndeezi, E. D. Charlebois, and P. J. Rosenthal. 2001. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet 358: 368-374.
196. Su, X., L. A. Kirkman, H. Fujioka, and T. E. Wellems. 1997. Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91:593-603.
197. Sudre, P., J. G. Breman, and J. P. Koplan. 1990. Delphi survey of malaria mortality and drug resistance in Africa. Lancet 335:722.
198. Sullivan, D. J., Jr., I. Y. Gluzman, D. G. Russell, and D. E. Goldberg. 1996. On the molecular mechanism of chloroquine's antimalarial action. Proc. Natl. Acad. Sci. USA 93:11865-11870.
199. Takechi, M., M. Matsuo, C. Ziba, A. Macheso, D. Butao, I. L. Zungu, I. Chakanika, and M. D. Bustos. 2001. Therapeutic efficacy of sulphadoxine/pyrimethamine and susceptibility in vitro of P. falciparum isolates to sulphadoxine-pyrimethamine and other antimalarial drugs in Malawian children. Trop. Med. Int. Health 6:429-434.
200. Talisuna, A. O., J. Kyosiimire-Lugemwa, P. Langi, T. K. Mutabingwa, W. Watkins, E. Van Marck, T. Egwang, and U. D'Alessandro. 2002. Role of the pfcrt codon 76 mutation as a molecular marker for population-based surveillance of chloroquine (CQ)-resistant Plasmodium falciparum malaria in Ugandan sentinel sites with high CQ resistance. Trans. R. Soc. Trop. Med. Hyg. 96:551-556.
201. Talisuna, A. O., P. Langi, N. Bakyaita, T. Egwang, T. K. Mutabingwa, W. Watkins, E. Van Marck, and U. D'Alessandro. 2002. Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors? Trans. R. Soc. Trop. Med. Hyg. 96:310-317.
202. Talisuna, A. O., P. Langi, T. K. Mutabingwa, E. Van Marck, W. Watkins, T. G. Egwang, and U. D'Alessandro. 2003. Population based validation of DHFZ gene mutations for the prediction of sulphadoxine-pyrimethamine resistance in Uganda. Trans. R. Soc. Trop. Med. Hyg. in press.
203. Thimasarn, K., S. Pinichpongse, S. Malikul, W. Rooney, and S. Tansophalaks. 1990. Phase III double-blind comparative study of Fansimef and Lariam for the curative treatment of Plasmodium falciparum infections in Thailand. Southeast Asian J. Trop. Med. Public Health 21:404-411.
204. Thompson, P. E., and L. M. Werbel. 1972. Antimalarial agents: chemistry and phamacology. In G. deStevens (ed.), Medicinal chemistry. Academic Press, Inc., New York, N.Y.
205. Tinto, H., E. B. Zoungrana, S. O. Coulibaly, J. B. Ouedraogo, M. Traore, T. R. Guiguemde, E. Van Marck, and U. D'Alessandro. 2002. Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso during a 3-year period, 1998-2000. Trop. Med. Int. Health 7:925-930.
206. Titanji, V. P., T. Nkuo-Akenji, W. Ntopi, and R. Djokam. 2001. Reduced levels of chloroquine resistant Plasmodium falciparum in selected foci of the South West Province, Cameroon. Cent. Afr. J. Med. 47:145-149.
207. Tjitra, E., S. Suprianto, B. J. Currie, P. S. Morris, J. R. Saunders, and N. M. Anstey. 2001. Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 65:309-317.
208. Trape, J. F. 2001. The public health impact of chloroquine resistance in Africa. Am. J. Trop. Med. Hyg. 64:12-17.
209. Trape, J. F., G. Pison, M. P. Preziosi, C. Enel, A. Desgrees du Lou, V. Delaunay, B. Samb, E. Lagarde, J. F. Molez, and F. Simondon. 1998. Impact of chloroquine resistance on malaria mortality. C. R. Acad. Sci. III 321:689-697.
210. Treeprasertsuk, S., P. Viriyavejakul, U. Silachamroon, S. Vannphan, P. Wilairatana, and S. Looareesuwan. 2000. Is there any artemisinin resistance in falciparum malaria? Southeast Asian J. Trop. Med. Public Health 31:825-828.
211. Triglia, T., J. G. Menting, C. Wilson, and A. F. Cowman. 1997. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 94:13944-13949.
212. van Vugt, M., A. Brockman, B. Gemperli, C. Luxemburger, I. Gathmann, C. Royce, T. Slight, S. Looareesuwan, N. J. White, and F. Nosten. 1998. Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. Antimicrob. Agents Chemother. 42:135-139.
213. Verdier, F., J. Le Bras, F. Clavier, I. Hatin, and M. C. Blayo. 1985. Chloroquine uptake by Plasmodium falciparum-infected human erythrocytes during in vitro culture and its relationship to chloroquine resistance. Antimicrob. Agents Chemother. 27:561-564.
214. Verhoeff, F. H., B. J. Brabin, P. Masache, B. Kachale, P. Kazembe, and H. J. van der Kaay. 1997. Parasitological and haematological responses to treatment of Plasmodium falciparum malaria with sulphadoxine-pyrimethamine in southern Malawi. Ann. Trop. Med. Parasitol. 91:133-140.
215. Vieira, P. P., A. M. das Gracas, L. H. da Silva, I. Gonzalez-Jimenez, and M. G. Zalis. 2001. Analysis of the PfCRT K76T mutation in Plasmodium falciparum isolates from the Amazon region of Brazil. J. Infect. Dis. 183: 1832-1833.
216. von Seidlein, L., K. Bojang, P. Jones, S. Jaffar, M. Pinder, S. Obaro, T. Doherty, M. Haywood, G. Snounou, B. Gemperli, I. Gathmann, C. Royce, K. McAdam, and B. Greenwood. 1998. A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfldoxine in the treatment of uncomplicated falciparum malaria in African children. Am. J. Trop. Med. Hyg. 58:638-644.
217. von Seidlein, L., M. Jawara, R. Coleman, T. Doherty, G. Walraven, and G. Targett. 2001. Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. Trop. Med. Int. Health 6:92-98.
218. Warsame, M., A. Abdillahi, O. N. Duale, A. N. Ismail, A. M. Hassan, A. Mohamed, and A. Warsame. 2002. Therapeutic efficacy of chloroquine and sulfadoxine/pyrimethamine against Plasmodium falciparum infection in Somalia. Bull. W. H. O. 80:704-708.
219. Warsame, M., V. A. Kilimali, W. H. Wernsdorfer, M. Lebbad, A. S. Rutta, and O. Ericsson. 1999. Resistance to chloroquine and sulfadoxine-pyrimethamine in Plasmodium falciparum in Muheza district, Tanzania. Trans. R. Soc. Trop. Med. Hyg. 93:312-313.
220. Warsame, M., W. H. Wernsdorfer, G. Huldt, and A. Bjorkman. 1995. An epidemic of Plasmodium falciparum malaria in Balcad, Somalia, and its causation. Trans. R. Soc. Trop. Med. Hyg. 89:142-145.
221. Watkins, W. M., and M. Mosobo. 1993. Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Trans. R. Soc. Trop. Med. Hyg. 87:75-78.
222. Wellems, T. E., L. J. Panton, I. Y. Gluzman, R. Do, V. R. W. Gwadz, A. Walker-Jonah, and D. J. Krogstad. 1990. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 345:253-255.
223. Wellems, T. E., and C. V. Plowe. 2001. Chloroquine-resistant malaria. J. Infect. Dis. 184:770-776.
224. Wernsdorfer, W. H. 1994. Epidemiology of drug resistance in malaria. Acta Trop. 56:143-156.
225. Wernsdorfer, W. H., and D. Payne. 1991. The dynamics of drug resistance in Plasmodium falciparum. Pharmacol. Ther. 50:95-121.
226. Whitby, M. 1997. Drug resistant Plasmodium vivax malaria. J. Antimicrob. Chemothcr. 40:749-752.
227. White, N. J., and W. Pongtavornpinyo. 2003. The de novo selection of drug-resistant malaria parasites. Proc. R. Soc. Lond. Ser. B 270:545-554.
228. White, N. 1999. Antimalarial drug resistance and combination chemotherapy. Philos. Trans. R. Soc. Lond. Ser. B 354:739-749.
229. White, N. J. 1999. Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia 41:301-308.
230. Wongsrichanalai, C., A. L. Pickard, W. H. Wernsdorfer, and S. R. Meshnick. 2002. Epidemiology of drug-resistant malaria. Lancet Infect. Dis. 2:209-218.
231. Wongsrichanalai, C., K. Thimasarn, and J. Sirichaisinthop. 2000. Antimalarial drug combination policy: a caveat. Lancet 355:2245-2247.
232. World Health Organization. 1996. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated malaria in areas with intense transmission. WHO/MAL/96.1077. World Health Organization, Geneva, Switzerland.
233. World Health Organization. 1965. Resistance of malaria parasites to drugs. W.H.O. Tech. Rep. Ser. 296:1-65.
234. World Health Organization. 1993. Implementation of the Global Strategy. Report of a WHO Study Group on the Implementataion of the Global Plan of Action for Malaria Control, 1993-2000. World Health Organization, Geneva.
235. World Health Organization. 1993. A global strategy for malaria control. World Health Organization, Geneva, Switzerland. 1993.
236. World Health Organization. 2001. Monitoring antimalarial drug resistance. Report of WHO Consultation, Geneva, Switzerland, 3-5 December 2001. WHO monographs WHO/CDS/CSR/EPH/2002.7 and WHO/CDS/RBM/ 2002.29. World Health Organization. Geneva, Switzerland.
237. World Health Organization. 2000. Severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94(Suppl. 1):S1-S90.
238. Zucker, J. R., E. M. Lackritz, T. K. Ruebush, A. W. Hightower, J. E. Adungosi, J. B. Were, B. Metchock, E. Patrick, and C. C. Campbell. 1996. Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens. Am. J. Trop. Med. Hyg. 55:655-060.